Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

DDMAC - Enforcement Actions - August 25, 2011

The Division of Drug Marketing, Advertising, and Communications (DDMAC) of the U.S. Food and Drug Administration (FDA), is pleased to inform you of a unique opportunity to participate in our second Enforcement Webinar, which was held on August 25, 2011. This is a pilot program in which DDMAC will give our stakeholders a chance to directly communicate with the Agency on clarifications or questions about the Warning Letters and Untitled Letters issued by DDMAC in a given quarter. This particular webinar covered Warning Letters and Untitled Letters issued from May 2011 to August 2011.

These focused Webinars will support DDMAC's mission to protect the public health by assuring prescription drug information is truthful, balanced, and accurately communicated.
 
View presentation slides here: Enforcement Webinar 8/25/11 (PDF - 655KB)
-
-